With the Trump administration announcing plans to impose 25% tariffs on pharmaceuticals, it reignites a critical discussion ...

The US FDA conducted an inspection at Orchid Pharma's Active Pharmaceutical Ingredient (API) manufacturing facility in ...

U.S. FDA classifies Aurobindo Pharma warehouse in New Jersey as Official Action Indicated, impacting compliance and ...

USFDA inspection at Aurobindo Pharma USA warehouse in New Jersey results in 5 observations, no business impact foreseen.

Subsequently, the US FDA has determined the inspection classification status of this warehousing facility as 'Official Action Indicated (OAI)'.

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

Cadwalader’s Martin Weinstein says that weakening Foreign Corrupt Practices Act enforcement removes a shield for ethical US ...

In the backdrop of the US-India dialogue on tariffs, the Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian ...

The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report ...

As the market opens for a new trading day, here are some stocks that are in focus. From BHEL’s new contract to Glenmark ...

Voluntary action indicated (VAI) is suggested when violations are found, but the problems do not justify further regulatory ...

Investor Summit has drawn US$115 billion in investments, alongside the launch of its Industrial Policy 2025-30.